Wall Street analysts expect Albemarle Corporation (NYSE:ALB) to report $1.07 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Six analysts have issued estimates for Albemarle Corporation’s earnings, with the lowest EPS estimate coming in at $1.05 and the highest estimate coming in at $1.13. Albemarle Corporation reported earnings of $0.91 per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 17.6%. The firm is scheduled to announce its next quarterly earnings results on Monday, November 6th.

On average, analysts expect that Albemarle Corporation will report full year earnings of $4.36 per share for the current financial year, with EPS estimates ranging from $4.30 to $4.40. For the next financial year, analysts anticipate that the company will post earnings of $5.00 per share, with EPS estimates ranging from $4.74 to $5.20. Zacks’ earnings per share averages are a mean average based on a survey of research firms that follow Albemarle Corporation.

Albemarle Corporation (NYSE:ALB) last announced its quarterly earnings data on Monday, August 7th. The specialty chemicals company reported $1.13 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.11 by $0.02. Albemarle Corporation had a return on equity of 11.59% and a net margin of 31.49%. The firm had revenue of $737.25 million during the quarter, compared to the consensus estimate of $735.50 million. During the same quarter in the previous year, the company posted $0.93 earnings per share. The business’s revenue was up 10.1% on a year-over-year basis.

Several equities research analysts have recently issued reports on the company. KeyCorp reaffirmed a “buy” rating and issued a $125.00 price objective on shares of Albemarle Corporation in a research note on Sunday, September 3rd. Jefferies Group LLC set a $144.00 price target on Albemarle Corporation and gave the stock a “buy” rating in a research note on Monday, August 21st. CIBC assumed coverage on Albemarle Corporation in a research note on Thursday, August 17th. They set an “outperform” rating and a $133.00 price target for the company. Oppenheimer Holdings, Inc. assumed coverage on Albemarle Corporation in a research note on Wednesday, August 16th. They set an “outperform” rating and a $133.00 price target for the company. Finally, BidaskClub lowered Albemarle Corporation from a “buy” rating to a “hold” rating in a research note on Saturday, August 12th. Seven investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. Albemarle Corporation presently has an average rating of “Buy” and an average price target of $110.94.

WARNING: This story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/09/15/albemarle-corporation-alb-expected-to-post-earnings-of-1-07-per-share.html.

Shares of Albemarle Corporation (NYSE ALB) traded up 0.33% during mid-day trading on Friday, reaching $126.41. The company’s stock had a trading volume of 293,144 shares. The company has a market cap of $13.96 billion, a PE ratio of 16.17 and a beta of 1.61. The company has a 50-day moving average price of $116.66 and a 200 day moving average price of $110.57. Albemarle Corporation has a 52-week low of $75.78 and a 52-week high of $126.59.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 2nd. Shareholders of record on Friday, September 15th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $1.28 annualized dividend and a yield of 1.02%. Albemarle Corporation’s payout ratio is currently 16.41%.

In other Albemarle Corporation news, Director Douglas L. Maine sold 10,000 shares of the firm’s stock in a transaction on Monday, June 19th. The stock was sold at an average price of $107.94, for a total transaction of $1,079,400.00. Following the transaction, the director now directly owns 24,150 shares in the company, valued at approximately $2,606,751. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Karen G. Narwold sold 20,000 shares of the firm’s stock in a transaction on Monday, June 19th. The stock was sold at an average price of $108.16, for a total value of $2,163,200.00. Following the transaction, the executive vice president now owns 45,120 shares in the company, valued at $4,880,179.20. The disclosure for this sale can be found here. Insiders have sold a total of 121,897 shares of company stock worth $13,458,086 over the last 90 days. 0.74% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Perigon Wealth Management LLC increased its holdings in Albemarle Corporation by 6.4% during the 2nd quarter. Perigon Wealth Management LLC now owns 7,046 shares of the specialty chemicals company’s stock worth $746,000 after purchasing an additional 426 shares during the period. W. E. Donoghue & Co. LLC purchased a new position in Albemarle Corporation during the 2nd quarter worth $2,173,000. Lord Abbett & CO. LLC purchased a new position in Albemarle Corporation during the 2nd quarter worth $11,681,000. USA Financial Portformulas Corp increased its holdings in Albemarle Corporation by 9.6% during the 2nd quarter. USA Financial Portformulas Corp now owns 30,985 shares of the specialty chemicals company’s stock worth $3,270,000 after purchasing an additional 2,725 shares during the period. Finally, Toronto Dominion Bank increased its holdings in Albemarle Corporation by 23.6% during the 2nd quarter. Toronto Dominion Bank now owns 37,565 shares of the specialty chemicals company’s stock worth $3,964,000 after purchasing an additional 7,165 shares during the period. Institutional investors own 84.01% of the company’s stock.

Albemarle Corporation Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Get a free copy of the Zacks research report on Albemarle Corporation (ALB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Albemarle Corporation (NYSE:ALB)

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.